Several studies have described the overexpression of Rictor in a variety of cancers including gliomas [11], [24]–[26], as well as, its ability to function as a haploinsufficiency gene protecting Pten+/− heterozygous mice from prostate cancer [44]. This evidence concerns the gene PTEN and prostate cancer.